RAPT Therapeutics Inc
RAPT7.840USD
+6.810+661.17%
Fechamento 06/17, 16:00（ET）Cotações atrasadas em 15 min
1.03BValor de mercado
PerdaP/L TTM
Mais detalhes de RAPT Therapeutics Inc Empresa
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.
Informações da empresa
Código da empresaRAPT
Nome da EmpresaRAPT Therapeutics Inc
Data de listagemOct 31, 2019
Fundado em2015
CEODr. Brian Wong, M.D., Ph.D.
Número de funcionários68
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 31
Endereço561 Eccles Ave
CidadeSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal94080
Telefone16504899000
Sitehttps://rapt.com/
Código da empresaRAPT
Data de listagemOct 31, 2019
Fundado em2015
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael F. Giordano, M.D.
Dr. Michael F. Giordano, M.D.
Independent Director
Independent Director
--
--
Dr. William (Bill) Ho, M.D., Ph.D.
Dr. William (Bill) Ho, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lori Lyons-Williams
Ms. Lori Lyons-Williams
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Brian Wong, M.D., Ph.D.
Dr. Brian Wong, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Dirk Brockstedt, Ph.D.
Dr. Dirk Brockstedt, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Rodney K. B. Young
Mr. Rodney K. B. Young
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Linda Kozick
Ms. Linda Kozick
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael F. Giordano, M.D.
Dr. Michael F. Giordano, M.D.
Independent Director
Independent Director
--
--
Dr. William (Bill) Ho, M.D., Ph.D.
Dr. William (Bill) Ho, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lori Lyons-Williams
Ms. Lori Lyons-Williams
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Brian Wong, M.D., Ph.D.
Dr. Brian Wong, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Dirk Brockstedt, Ph.D.
Dr. Dirk Brockstedt, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Medicxi Ventures (UK) LLP
16.90%
OrbiMed Advisors, LLC
9.93%
TCG Crossover Management, LLC
9.90%
Foresite Capital Management, LLC
9.45%
RTW Investments L.P.
8.89%
Other
44.94%
Investidores
Investidores
Proporção
Medicxi Ventures (UK) LLP
16.90%
OrbiMed Advisors, LLC
9.93%
TCG Crossover Management, LLC
9.90%
Foresite Capital Management, LLC
9.45%
RTW Investments L.P.
8.89%
Other
44.94%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
2.96%
Private Equity
2.84%
Hedge Fund
2.64%
Venture Capital
2.25%
Investment Advisor
1.68%
Research Firm
0.08%
Individual Investor
0.06%
Bank and Trust
0.01%
Family Office
0.01%
Other
87.49%
Participação acionária institucional
Atualizado em: ter, 4 de mar
Atualizado em: ter, 4 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
301
145.36M
110.11%
+83.62M
2024Q4
309
140.52M
106.54%
+100.36M
2024Q3
304
31.22M
87.82%
-13.95M
2024Q2
305
33.18M
93.85%
-9.52M
2024Q1
295
33.76M
95.60%
-5.47M
2023Q4
282
36.46M
106.02%
-3.53M
2023Q3
281
36.40M
105.98%
-3.26M
2023Q2
295
35.63M
103.77%
-4.21M
2023Q1
301
34.71M
101.29%
-3.14M
2022Q4
290
33.55M
97.48%
-1.41M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Medicxi Ventures (UK) LLP
22.35M
16.93%
+22.35M
--
Dec 31, 2024
OrbiMed Advisors, LLC
13.14M
9.95%
+13.14M
--
Dec 31, 2024
TCG Crossover Management, LLC
13.14M
9.95%
+13.14M
--
Dec 31, 2024
Foresite Capital Management, LLC
12.50M
9.47%
+12.50M
--
Dec 31, 2024
RTW Investments L.P.
11.76M
8.91%
+11.76M
--
Dec 31, 2024
BVF Partners L.P.
9.24M
7%
+9.24M
--
Dec 31, 2024
The Vanguard Group, Inc.
2.93M
2.22%
-8.95K
-0.30%
Jan 31, 2025
Redmile Group, LLC
6.48M
4.91%
+5.97M
+1.18K%
Dec 31, 2024
Deep Track Capital LP
6.01M
4.55%
+6.01M
--
Dec 31, 2024
Adar1 Capital Management LLC
1.17M
0.89%
+1.17M
+15.56K%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
Federated Hermes MDT Small Cap Core ETF
0.05%
iShares Micro-Cap ETF
0.01%
ProShares UltraPro Russell2000
0%
Nuveen ESG Small-Cap ETF
0%
Avantis US Small Cap Equity ETF
0%
Humankind US Stock ETF
0%
Invesco Dorsey Wright Healthcare Momentum ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Proshares Ultra Russell 2000
0%
Ver Mais
Federated Hermes MDT Small Cap Core ETF
Proporção0.05%
iShares Micro-Cap ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0%
Nuveen ESG Small-Cap ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
Humankind US Stock ETF
Proporção0%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção0%
Invesco Nasdaq Biotechnology ETF
Proporção0%
ProShares Ultra Nasdaq Biotechnology
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
